B. BRAUN MELSUNGEN AG

Manufacturer adverse-event records for B. BRAUN MELSUNGEN AG come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 1993–2026 · thin-book · elevated Death-code · injury-light

Volume signature

B. BRAUN MELSUNGEN AG is a thinner MAUDE footprint

B. BRAUN MELSUNGEN AG accounts for 5,805 FDA MAUDE reports (#334 of 443, thin-book tercile). Death-coded event_type share is 1.10% (elevated); Injury share 6.1% (injury-light).

What the volume reading shows for B. BRAUN MELSUNGEN AG

The standout signal for B. BRAUN MELSUNGEN AG is filing volume: 5,805 adverse-event reports in FDA MAUDE (#334 of 443, thin-book). Death-coded event_type share sits at 1.10% (elevated).

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 20 device types, led in this extract by Malfunction at 5,305 (91.4% of event_type total). Peak single-year volume reaches 655 reports across 20 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

5,805
Total Reports
64
Event-type Death
356
Injury Reports
20
Device Types

Event Types

Malfunction 5,305 (91.4%)
Injury 356 (6.1%)
Death 64 (1.1%)
49 (0.8%)
Other 31 (0.5%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

4,785 (81.3%)
Other 713 (12.1%)
Required Intervention 135 (2.3%)
Death 76 (1.3%)
R 62 (1.1%)
Hospitalization 61 (1.0%)
O 21 (0.4%)
Life Threatening 19 (0.3%)
Disability 9 (0.2%)
H 4 (0.1%)
D 3 (0.1%)

Yearly Trend

93
1993: 1
05
2005: 1
06
2006: 6
07
2007: 4
11
2011: 96
12
2012: 240
13
2013: 655
14
2014: 607
15
2015: 570
16
2016: 643
17
2017: 267
18
2018: 288
19
2019: 582
20
2020: 286
21
2021: 250
22
2022: 246
23
2023: 311
24
2024: 357
25
2025: 356
26
2026: 39